Expert: FTC Clinical Data Requirements A Likely Challenge For Medtech Companies
Executive Summary
Medtech Insight spoke to Sidley Austin LLP partner Jeff Senger about the challenges companies may face navigating the FTC’s updated health products guidance.
You may also be interested in...
FTC Health Products Guidance: Not Just For Dietary Supplements Anymore
The FTC has updated its guidance on health products advertising for the first time in 25 years with an expanded version that includes devices.
FTC Use of Expert Opinions On Supplement Ad Claim Support Cited In Guide
A "guiding principle" in the Federal Trade Commission's determination of the amount and type of evidence needed to substantiate a dietary supplement advertising claim is "what experts in the relevant area of study would generally consider to be adequate," the commission states in a business guide for supplement advertisers released Nov. 18.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.